Thursday's Winners & Losers: Chindex International

Fortress Investment Group (FIG Quote) reworked a deal with Penn National Gaming (PENN Quote) Thursday, as financial stocks ticked up slightly ahead of the holiday weekend.

Fortress and private equity firm Centerbridge Partners, which had agreed in June to buy Penn for $67 a share will now instead invest in the casino operator and pay a termination fee. Penn stock had declined 44% since last June. Fortress was trading down about 1% to $11.39; Penn was up 3% to $29.45.

Wachovia (WB Quote) dropped 3.1% to $14.90. The bank announced that it appointed Kevin O'Connor as its chief investment officer to Wachovia Global Securities Lending, a division of the bank that handles third-party lending.

Chindex International (CHDX Quote) said Wednesday post close that it received approval from health regulators in the People's Republic of China to introduce new products, including Intuitive Surgical's (ISRG Quote) daVinci S. Surgical System. Chindex shares rose 15% to $16.13 Thursday, and Intuitive Surgical's shares edged down 0.2% to $250.57.

Abbott Laboratories (ABT Quote) shares climbed on the Food and Drug Administration approval of its Xience V, a drug-eluting stent for patients with coronary artery disease. The antibiotic-coated mesh tube will compete with products by Boston Scientific (BSX Quote), Medtronic (MDT Quote) and Johnson & Johnson (JNJ Quote).

Abbott, which said it will launch the stent in the U.S. immediately, saw shares rise 1% to $54.80. Shares of competitor Boston Scientific, which makes the Taxus stent, edged down 4 cents to $12.37.